Trial intelligence / Profile preview

Ethanolamine oleate sclerotherapy for subcutaneous venous malformation in the oral and maxillofacial region (EOST-OMS)

jRCTs071180067Recruiting

Start
Oct 2009
Modality
Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of ethanolamine oleate in venous malformation (VM). Primary endpoint: Reduction rate. Started Oct 2009; status: recruiting.

02

Drugs

ethanolamine oleate
03

Conditions

venous malformation (VM)

Beyond the preview

Go deeper on jRCTs071180067.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCTs071180067.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call